Molnupiravir – UPSC Prelims

  • It is an anti-viral Covid-19 pill approved by Indian Drug regulator.
  • Molnupiravir was initially developed to treat influenza. Now it is being repurposed as an oral antiviral candidate to treat Covid-19 patients.
  • It works by introducing errors into the SARS-CoV-2 virus’ genetic code, which prevents the virus from further replicating.
  • The drug has been cleared for the treatment of adult patients with Covid-19 and who have a high risk of progression of the disease.
  • The drug is not authorised for use in patients less than 18 years, and initiation of treatment in patients requiring immediate hospitalisation.
  • The drug can be taken orally every 12 hours for five days.
  • UK and US has also approved it.
Scroll to Top